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http://www.biomedcentral.com/1471-2288/12/68RESEARCH ARTICLE Open AccessA review of statistical estimators for risk-adjusted
length of stay: analysis of the Australian and new
Zealand intensive care adult patient data-base,
2008–2009
John L Moran1* and Patricia J Solomon2 for the ANZICS Centre for Outcome and Resource Evaluation (CORE)
of the Australian and New Zealand Intensive Care Society (ANZICS)Abstract
Background: For the analysis of length-of-stay (LOS) data, which is characteristically right-skewed, a number of
statistical estimators have been proposed as alternatives to the traditional ordinary least squares (OLS) regression
with log dependent variable.
Methods: Using a cohort of patients identified in the Australian and New Zealand Intensive Care Society Adult
Patient Database, 2008–2009, 12 different methods were used for estimation of intensive care (ICU) length of stay.
These encompassed risk-adjusted regression analysis of firstly: log LOS using OLS, linear mixed model [LMM],
treatment effects, skew-normal and skew-t models; and secondly: unmodified (raw) LOS via OLS, generalised linear
models [GLMs] with log-link and 4 different distributions [Poisson, gamma, negative binomial and inverse-Gaussian],
extended estimating equations [EEE] and a finite mixture model including a gamma distribution. A fixed covariate
list and ICU-site clustering with robust variance were utilised for model fitting with split-sample determination
(80%) and validation (20%) data sets, and model simulation was undertaken to establish over-fitting (Copas test).
Indices of model specification using Bayesian information criterion [BIC: lower values preferred] and residual analysis
as well as predictive performance (R2, concordance correlation coefficient (CCC), mean absolute error [MAE]) were
established for each estimator.
Results: The data-set consisted of 111663 patients from 131 ICUs; with mean(SD) age 60.6(18.8) years, 43.0% were
female, 40.7% were mechanically ventilated and ICU mortality was 7.8%. ICU length-of-stay was 3.4(5.1) (median 1.8,
range (0.17-60)) days and demonstrated marked kurtosis and right skew (29.4 and 4.4 respectively). BIC showed
considerable spread, from a maximum of 509801 (OLS-raw scale) to a minimum of 210286 (LMM). R2 ranged from
0.22 (LMM) to 0.17 and the CCC from 0.334 (LMM) to 0.149, with MAE 2.2-2.4. Superior residual behaviour was
established for the log-scale estimators. There was a general tendency for over-prediction (negative residuals) and
for over-fitting, the exception being the GLM negative binomial estimator. The mean-variance function was best
approximated by a quadratic function, consistent with log-scale estimation; the link function was estimated (EEE) as
0.152(0.019, 0.285), consistent with a fractional-root function.
Conclusions: For ICU length of stay, log-scale estimation, in particular the LMM, appeared to be the most
consistently performing estimator(s). Neither the GLM variants nor the skew-regression estimators dominated.* Correspondence: john.moran@adelaide.edu.au
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Length of stay during an intensive care unit (ICU) or hos-
pital admission is a function of diverse patient and organ-
isational input variables [1]. It is widely used as an
indicator of performance [2] and is a determinant of costs,
although resource allocation is also known to affect length
of stay [3]. Not surprisingly, ICU length of stay has been
the subject of frequent analysis [4-9], with the majority of
studies presenting cross-sectional analyses over a relatively
short periods of months [10] to 1–2 years [9].
ICU patient length of stay (and costs) demonstrate
skewed distribution and various statistical modelling
strategies have been employed in analysis of such data
[11-14]; albeit linear regression (ordinary least squares
regression, OLS) of the logged dependent variable has
demonstrated a remarkable persistence [15]. Individual
patient data, as accessed from ICU data-bases, have an
intrinsic hierarchical structure (patients within ICUs)
and due analytic consideration of this structure is also
appropriate [16]. Using such data from the Australian
and New Zealand Intensive Care (ANZICS) adult patient
database (APD) [17], calendar years 2008–2009, the pur-
pose of this paper was to: (i) compare the predictive
performance and model specification of conventional
estimators for skewed data (ICU length-of-stay); OLS (with
both raw and log-scaled dependent variable) and general-
ised linear models (GLMs [14]), with more innovative
approaches: multilevel or hierarchical linear mixed models
(LMM) incorporating random effects [11,16]; extended
generalised linear models (EEE) with flexible link and vari-
ance functions [18]; estimators utilising skew-normal and
skew-t multivariate distributions [19]; and finite mixture
(FMM) models which consider the dependent variable as a
mixture of distributions [20-22]; and (ii) determine the
effect of (ICU) mortality outcome upon length of stay,
allowing for “endogenous variable bias” [23] by means of a
treatment-effects model [24,25] where specific allowance is
made for the correlation of independent predictors and
error terms. Under such conditions, model coefficients are
biased [26].Methods
The ANZICS adult patient database (APD) is a bi-
national (Australia and New Zealand) voluntary data col-
lection of individual ICU admissions which commenced
in 1990. The data set requirements are specified in a
data dictionary [27]. The current data-base does not in-
corporate coronary care units. Data is collected at the
individual ICU and uploaded to the central repository
(ANZICS APD) for processing and quality assurance;
which consists of a cycle of error and exception checks,
site feed-back, resubmission and incorporation into a
final reporting data-set.The ANZICS APD was interrogated to define an appro-
priate patient set, over the time period 2008–2009. Physio-
logical variables collected were the worst in the first 24
hours after ICU admission. All first ICU admissions to a
particular hospital for the period 2008–2009 were selected.
Exclusions: patients with an ICU length of stay≤ 4 hours;
and patients aged< 16 years of age. Specific attention was
directed to the fidelity of severity of illness records; in par-
ticular the scoring of the Glasgow Coma Score (GCS).
Records were used only when all three components of the
GCS were provided. Records where all physiological vari-
ables were missing were excluded and for the remaining
records, missing variables were replaced to the normal
range and weighted accordingly [28]. ICU length of stay,
initially recorded in hours was transformed to days; patients
with an ICU length of stay > 60 days were not considered,
no formal trimming methods were employed [29].
Statistical methods
Continuous variables were reported using mean (SD), ex-
cept where otherwise indicated; categorical variables were
analysed using the Chi-squared test. To avoid the con-
founding effect of calendar time, patient data over the two
years 2008 and 2009 was pooled. Distributional form of
continuous variables of interest was by means of histogram,
hanging rootogram [30,31] or violin plots [32]. The “hang-
root”, an alternative to the histogram, compares an empir-
ical distribution with a theoretical distribution by means of
“hanging” spikes from the theoretical distribution. The
spike lengths represent bin counts, using the square root of
the frequencies to stabilise the sampling variation across
bins and make deviations in the tails, where the counts are
small, more visible. Deviations are shown as deviations
from a horizontal line (y=0) instead of deviations from a
curve (the density function) in order to facilitate identifica-
tion of patterns of deviation. The violin plot is a modifica-
tion of the box plot that adds plots of the estimated kernel
density to the summary statistics displayed by box plots
[33], incorporates a marker for the median of the data, a
box indicating the interquartile range, and spikes extending
to the upper- and lower-adjacent values; overlaid is a dens-
ity plot. Kernel density estimates are modifications of the
histogram (a “smoothed” histogram), where densities are
the continuous analogues of proportions (derivatives of the
cumulative distribution function, so that areas under the
density function read off as probabilities) [34]. Kurtosis
(a measure of the heaviness of the tails of the distribution)
and skewness were quantitatively expressed (a normal dis-
tribution having a skewness of 0 and a kurtosis of 3)
according to standard formulae [35].
Predictor variables considered were
a) Continuous: age (in years), severity of illness score
(Acute Physiology and Chronic Health Evaluation
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computation. The predictive effect of these variables
was entered initially as both linear and quadratic.
b) Categorical: these were parameterized as indicator
variables with the reference level ( 0) indicated in
parentheses in the following list: gender (female);
mechanical ventilation (not ventilated); ICU level, as
defined in the ANZICS database, as Rural/Regional,
Metropolitan, Tertiary and Private (Tertiary); State
of origin; that is New Zealand and the States of the
Commonwealth of Australia (New South Wales
(NSW), the largest contributor); patient surgical
status as post-elective surgery, post-emergency
surgery and non-surgical (non-surgical); descriptors
of ICU admission primary organ system dysfunction,
these being a consolidation of the “diagnostic
categories” of the APACHE algorithms:
cardiovascular, gastrointestinal, metabolic,
neurologic, respiratory, trauma, renal/genitourinary
(cardiovascular); mean annual ICU volume across all
ICUs (0 <mean volume; 1 >mean volume);
Died-in-ICU (0 =Alive, 1 =Died)
Clinically meaningful combinations of variables and their
interactions were assessed for effect; to preserve clinical
transparency, higher order interactions were explored, but
not entertained in the final model. The potential for mul-
tiple colinearity was tested using the variance inflation fac-
tor (VIF) and condition number (CN); where VIF< 10 and
CN less than “30 or more” [37] were desirable.
ICU length of stay was modelled (with a fixed covari-
ate list, and clustering on ICU site with robust variance
[38]) via the estimators;
1. OLS using length of stay as a raw and a logged
dependent variable. For the log OLS the expected





variance is assumed to be proportional to the mean
squared. Prediction is on the log-scale (the geometric
mean) and re-transformation is dependent upon the
distribution of the error term: if normally distributed
u^ xið Þ ¼ exp x0 β^
 
þ 0:5σ^E2[39,40]; under
homoscedasticity μ^ xið Þ ¼ φ^: exp x0iβ^
 
where φ^ is the
estimated smearing factor and is usually between 1
and 4 [41,42].
2. LMM (logged length of stay) using maximum
likelihood for model estimates. Potential modifying
covariates were computed as fixed effects; ICU-year
units as random intercepts (or “levels”) and random
coefficients (“slopes”: APACHE III and APACHE III
squared, age and ventilation status) were
incorporated into the model fit.
3. A treatment effects model, log-dependent variable,
via the Stata™ module “treatreg” as initially describedby Cong and Drukker [43]. A treatment-effects model is
a two-equation system estimator (non-linear probit [44]
and linear OLS), in which the effect of an endogenous
binary variable (in this case, “Died-in-ICU”) on the
continuous dependent variable is estimated by
maximum likelihood [24,45]. Formally, the model is
expressed in two equations [43]: the regression equation
yi ¼ xiβþ δzj þ Ej, where zj is the endogenous dummy
variable indicating treatment assignment (=1, if zj > 0;
or not, zj ¼ 0). The outcome treatment-effect,
estimated by the probit equation, is understood as being
determined by an unobservable latent variable (zj ), a
linear function of covariates (wj), and a random
component (uj): zj ¼ wjγ þ uj. The covariates entered
into the outcome treatment equation were: age
mechanical ventilation status, APACHE III score and its
square, patient surgical status and the interaction with
ventilation status, descriptors of ICU admission primary
organ system dysfunction. As these covariates were
commensurate with those of the OLS equation, a
question of model identification arises [25]. However, as
shown by Maddala, such a model is identified even if
the error terms are not independent and the variable
list is identical in the two equations [45].
4. GLMs [14] with a log link (relating the conditional
mean to the covariates) and either a gamma, inverse
Gaussian or Poisson family (specifying the
relationship between the variance and the mean)
[14,42] using maximum likelihood. The possibility of
over-dispersion with the Poisson GLM was tested by
calculating z ¼ yiμ^ ið Þ2yiμ^ i ﬃﬃﬃﬃ2p and regressing z as a
constant-only model; significance of z indicating
over-dispersion [46]. In the presence of over-
dispersion, the Poisson GLM model prediction and
performance measures were replicated using a GLM
negative binomial (NB2) model with log link [47].
For this model the variance function is given as
μþ αμ2, where μ is the mean and α the
heterogeneity or over-dispersion parameter,
estimated by maximum likelihood (in GLM Poisson
regression, α=0). The negative binomial may be also
be conceptualised as a “waiting time” distribution
(the number of days to discharge), a generalisation of
the geometric distribution [5].
5. EEE model allowing simultaneous estimation of
flexible parametric link (Box-Cox function [48]) and
variance functions, as implemented by Basu in the
Stata™ user-written module “pglm”, using the raw
dependent variable, scaled to the mean [18,49].
Expected values, conditional on covariates, are an
inverse Box-Cox function of the linear predictor:
x
0
β ¼ g ui; λð Þ ¼ μλi  1
 
=λ if λ 6¼ 0; log μð Þ if λ ¼ 0.
The default power variance function was used, which
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θ2 . The variance functions include the Poisson,
gamma and inverse Gaussian variance functions as
special cases [50]; as with linear OLS, where
λ ¼ 1and θ2 ¼ 0 [51]. Estimation of regression and
link parameters is via an extension of quasi-
likelihood, and the variance parameters by additional
estimating equations; that is, the EEE is a semi-
parametric model. The link function transforms the
mean of the outcome (not the outcome), overcoming
the retransformation problem [50].
6. Regression utilising the skew-t and skew-normal
distribution as implemented by Marchenko and Genton
in the Stata™ user-written modules “skewtreg” and
“skewnreg” respectively [19]. These distributions, fitted
to the transformed (log) dependent variable, are
(equivalently) the log-skew-t and log-skew-normal
distributions by virtue of the correspondence which
connects the normal and log-normal distributions
[52,53]. The skew-normal distribution, beside location
and scale parameters, has an additional shape parameter
(α; if α=0 normal distribution) regulating
distributional asymmetry; the skew-t distribution allows
for asymmetry and heavier tails via shape (α) and
degrees-of-freedom (v) parameters [19]. Regression and
other model parameters are estimated by maximum
likelihood.ble 1 Demographics of ICU-hospital level, ventilation and s
U hospital Overall Not-ventilated
vel/variable Non-surgical Elective surgical Eme
ral (13.05%)
U length of stay (days) 3.3 (4.6) 2.6 (3.1) 2.2 (2.6) 2.5 (3
ACHE III score 49.3(29.2) 42.6 (23.9) 36.4(16.1) 40.8
e (years) 60.1 (19.5) 58.5 (20.4) 63.8 (16.1) 61.3
males 55 55 56 51
etropolitan (18.45%)
U length of stay (days) 3.7 (5.2) 3.1 (4.3) 1.8 (2.2) 2.3 (3
ACHE III score 55.5 (30.6) 50.4 (26.3) 37.3 (16.7) 44.9
e (years) 59.9 (19.2) 58.6 (19.9) 63.8 (16.1) 61.3
males 55 52 58 50
rtiary (44.49%)
U length of stay (days) 3.9 (5.7) 3.0 (4.3) 1.5 (1.8) 2.4 (3
ACHE III score 57.0(30.1) 51.6 (26.1) 38.7 (15.8) 45.2
e (years) 58.3 (19.2) 57.3 (20.1) 62.8 (16.2) 59.7
males 60 55 60 56
ivate (24.01%)
U length of stay (days) 2.4 (3.7) 3.2 (4.5) 1.5 (1.8) 1.9 (2
ACHE III score 43.7(22.4) 49.6 (22.9) 35.3 (15.2) 40.5
e (years) 65.5 (16.0) 68.4 (16.9) 63.4 (16.0) 64.6
males 57 52 54 477. FMM, with two mixing components of a gamma and
negative binomial (NB1 and NB2) densities, using the
user-written Stata™ module “fmm”, version 2.0.0, by
Deb [54]. In a FMM, the random variable is assumed
to be drawn from a super-population that is an
additive mixture of distinct subpopulations or classes
(C) in proportions π1; . . .πC ;where
PC
j¼1πj ¼
1; 0 < πj < 1 j ¼ 1; . . .Cð Þ [20-22]. The C-point
finite mixture model is given by f ðyijΘÞ ¼Pc
j¼1πifjðyijθjÞ, where the mixing probabilities πj are
estimated with other parameters (Θ) [20-22]. The θj
is a parameter vector characterizing the component
density function fj(), the component density
belonging to different parametric families
(implemented in “fmm” are gamma, lognormal,
negative binomial, normal, Poisson and Student-t).
Estimation is by maximum likelihood.
Model adequacy was gauged by (i) progressive reduction
in AIC (Akaike Information Criterion, for nested models)
and BIC (Bayesian Information Criterion, for non-nested
models) [55], both of which are penalised (with respect to
number of observations and model parameters) likelihood
methods for model determination (ii) likelihood ratio tests
where appropriate and (iii) normality and lack of heterosce-
dasticity of residuals based upon graphical analysis [14].urgical status: mean(SD)
Ventilated
rgency surgical Non-surgical Elective surgical Emergency surgical
.6) 5.7(7.1) 4.7 (4.5) 5.4 (6.4)
(20.8) 78.4 (33.6) 54.7 (25.3) 70.5 (30.8)
(20.5) 57.9 (18.3) 67.8 (15.1) 64.0(19.0)
58 66 56
.4) 5.7 (6.8) 4.7 (5.8) 5.3 (6.6)
(23.6) 76.4 (34.5) 55.5 (23.1) 65.5 (29.7)
(20.5) 57.7 (19.2) 66.0 (15.2) 63.3 (19.2)
56 66 59
.9) 5.9 (7.2) 2.7 (4.1) 5.5 (6.7)
(22.7) 73.4 (34.6) 48.3 (19.0) 60.8 (27.8)
(20.1) 54.6 (19.6) 64.2 (15.6) 57.9 (19.9)
62 63 62
.7) 6.6 (7.9) 3.2 (3.9) 4.5 (6.6)
(19.1) 78.1 (32.1) 52.3 (21.7) 62.48 (29.4)
(17.9) 68.9 (15.7) 68.4 (13.8) 67.9 (16.1)
54 61 49
Moran and Solomon BMC Medical Research Methodology 2012, 12:68 Page 5 of 17
http://www.biomedcentral.com/1471-2288/12/68Residuals were generated from the fitted model according
to the scale of estimation [50]. The final model was devel-
oped on a determination set (80% of data) and validated on
a validation set (20% of data); the random samples being
stratified by (the 2) calendar-years. Predicted values were
generated with continuous covariates centred and categor-
ical covariates held at the reference category, as above, and
in the presence of a logged dependent variable (length of
stay) back-transformation to the original metric (days)
utilised Duan’s smearing estimate [41]. Distributional form
of the raw-scale predictions (determination and validation)
were displayed using violin plots. Final model performance
was assessed by R2 (on the “day” scale [56]) computed as
the square of the correlation between predicted and
observed length of stay [57]; Lin’s concordance correlation
coefficient (between raw and predicted raw length of stay
[58]); mean absolute error (MAE); and root mean squared
error (RMSE) [12,14]. Supplementary diagnostic analyses
[15,40,50,51,59] were also performed, using:
(i) user-written Stata™ code provided by Norton [60]
and Jones [61]; the “GLM family” test (in GLMs there
is accommodation of skewness, in particular, via the
variance [42]: Var[y|x] =α.[E(y|x)]; therefore test if
γ=0 (Gaussian), = 1 (Poisson), = 2 (gamma), and=3
(inverse Gaussian)); and the “COPAS” test: testing for
over-fitting via split sample (50:50) cross-validation
(1000x) using a version of the test initially formulated











0 20 40 60
ICU stay: days
Figure 1 Histograms of ICU length of stay with normal curve overlay:raw-scale length of stay and a significant difference of
βpredictions from unity suggests over-fitting [42]).
(ii) With respect to the particular problem that raw-scale
variance was a power function of the raw-scale
mean function, the (modified [40,59]) Park test [63]
was implemented. Squared residuals from a
provisional model (GLM or OLS log-scale) were
regressed (using a GLM with robust variance
estimate and log-link) on the predictions (^y) from
the same model, both log transformed:
ln yi  y^i
 2  ¼ γ0 þ γ1ln y^i
 þ vi; the coefficient
on γ(see (i), above) indicating the GLM variance
function.
(iii) a modified Hosmer-Lemeshow goodness-of-fit (F) test
[50,64], regressing the particular model residual
distribution against deciles of the linear predictor
(using OLS with robust variance). Graphical plots of
the calibration of regression decile-parameter
estimates against deciles of the linear predictor were
undertaken; positive parameter estimates above the
null-line ( 0) indicate under-prediction and negative
estimates indicate over-prediction [50].
As the interpretation of β coefficients is not invariant to
model link functions [18], the average marginal effect [65,66]
of ICU mortality upon length of stay (“Died-in-ICU”) was
estimated using the “margins” routine of Stata™ and the
specific computations provided by Basu [49] for the EEE es-
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ICU stay: square-root days
Distribution: normal
Figure 2 Hanging rootograms displaying approximations of the empirical distribution of ICU length of stay, and transformations (log
and square-root), to various theoretical distributions. Shaded areas a tip of spiles are 95% CI.
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sion dependent variable (“y”,  ICU length-of-stay) of a
change in a regressor(s) of interest (in this case the binary
variable “Died-in-ICU”) [66]. The impact of progressive
increases in patient severity of illness (APACHE III score)
was elucidated by the “marginsplot” module of Stata™ [67],
using the contrast across the 1 ( Died)/0 ( Alive) binary
variable “Died-in-ICU”. Because of the technical problem
of applying the Duan estimator directly to a contrast of the
predicted logs in the log-scale estimators (exponentiating
the difference and then multiplying by a function of the
residuals would not produce an estimate directly compar-
able to the contrast produced after regression performed
on raw-scale data), the illustrative plots were generated
using raw-scale OLS and a log-link Gaussian family GLM.
Stata™ (Version 12 MP, 2011; Stata Corporation, Col-
lege Station, Texas) statistical software was used.Results
The database for the period 2008–2009 contained
records of 114798 patients with exclusion (4.20%) ofpatients having: ICU length of stay < 4 hours, incomplete
GCS or APACHE III records. The final data set had
missing ICU length of stay in 0.03% and 141 patients
(0.001%) with ICU length of stay > 60 days (mean 81.98
(24.37), range 60.05-199.67) not considered in analysis.
Patients (n= 111663) admitted to 131 ICUs in the same
number of hospitals, were of mean(SD) age 60.6(18.8)
years, APACHE III score 52.5(28.9); 43.0% were female,
40.7% were mechanically ventilated (on the day of ad-
mission) and ICU mortality was 7.8%. ICU length of stay
was 3.4(5.1) (median 1.8, inter-quartile range 2.8 (0.93-
3.7)) days. Summary statistics of length of stay, APACHE
III score, age and gender by ventilation status and pa-
tient surgical type are shown in Table 1. Overall ICU
length of stay and the log transform are displayed in
histogram form with normal curve overlay in Figure 1
(left and right panels respectively); raw scale length of
stay demonstrated marked kurtosis and right skew (29.4
and 4.4 respectively) whilst the log transform demon-
strated a more symmetrical distribution (kurtosis 3.1
and skewness 0.5). Comparison of the empirical distribu-
tion of ICU length of stay and its’ log and square root
Table 2 Performance comparisons for various estimators
Performance index BIC R^2 R^2 CCC CCC MAE MAE RMSE RMSE Residual Normality Residual vs
Model Determination Determination Validation Validation Determination Determination Validation Determination Validation P-P plot Q-Q plot fitted
set data-set data-set data-set data-set Symmetry
(n = 86740) (n = 21678)
OLS: raw scale 509801.4 0.19 0.18 0.313 0.308 2.4 2.4 4.6 4.5 No + ve skew No
OLS: log scale 216183.2 0.18 0.18 0.293 0.290 2.4 2.4 4.6 4.5 Yes + ve skew Yes




244883.2 0.18 0.17 0.296 0.294 2.4 2.4 4.6 4.5 Yes + ve skew Yes
(Raw scale) 539291.4
GLM: family(Poisson), link(log) 479143.3 0.19 0.18 0.321 0.314 2.4 2.4 4.5 4.5 No + ve skew No
GLM: family(negbin), link(log) 375021.6 0.19 0.18 0.322 0.316 2.4 2.4 4.5 4.5 No + ve skew No
GLM: family(gamma), link(log) 355449.9 0.19 0.18 0.322 0.317 2.4 2.4 4.6 4.5 No + ve skew# No
GLM: 365186.1 0.19 0.18 0.322 0.317 2.4 2.4 4.6 4.6 No + ve skew# No
family(inverse Gaussian),
link(log)
EEE: Not estimable 0.19 0.18 0.320 0.316 2.4 2.4 4.6 4.6 No + ve skew# No
Log-skew-t regression 213465.5 0.18 0.17 0.285 0.283 2.4 2.4 4.6 4.6 Yes neg skew# No
(Raw scale) 349461.3
Log-skew-normal regression 214216.4 0.18 0.17 0.317 0.273 2.6 2.4 4.6 4.6 No neg skew# No
(Raw scale) 436227.8
FMM: raw scale 329774.9 0.18 0.18 0.151 0.149 2.2 2.2 5.0 5.0 No + ve skew# Yes
LLM; Linear mixed model (random coefficient model). CCC; concordance correlation coefficient. Negbin; negative binomial. P-P plot; standardized normal probability plot. Q-Q plot; plot of the quantiles of the residuals
against the quantiles of the normal distribution . +ve skew#; marked positive skew. neg skew#; marked negative skew. Residuals vs fitted; increase spread of residuals with increment of fitted values (predicted length
of stay). MAE; mean absolute error. RMSE; root mean square error. FMM; finite mixture model. R2, CCC,MAE and RMSE were computed on the back-transformed “day” scale (for the linear mixed model, OLS-log,























Table 3 Specification tests for various estimators
Correlation Residuals Hosmer-Lemeshow (F) test Copas test
LP vs Skewness Kurtosis Determination Validation
residuals
OLS raw scale@ 1.00 4.33 32.74 0.0001 0.0001 0.996(0.993, 0.998)
OLS log scale@ 0.03 0.25 3.58 0.0001 0.0001 1.079(1.063, 1.094)
LMM log scale@ 0.008 0.25 3.76 0.0001 0.0001 1.054(1.036, 1.072)
Treatment effects model: log scale 0.150 0.27 3.58 0.0001 0.0001 1.043(1.025, 1.062)
GLM: family(Poisson), link(log)# 0.0001 2.37 13.41 0.0001 0.0001 0.940(0.899, 0.981)
GLM: family(negative binomial), link(log)# 0.0001 1.59 8.14 0.0001 0.0001 0.967(0.926, 1.008)
GLM: family(gamma), link(log) # 0.0001 1.26 6.60 0.0001 0.0001 0.923(0.882, 0.965)
GLM: family(inverse Gaussian), link(log) # 0.0002 0.20 4.98 0.0001 0.0001 0.776(0.717, 0.835)
EEE: raw scale 0.002 4.25 32.44 0.0001 0.002 0.956(0.957,0.958)
Skew-t regression: log scale 0.0001 0.31 3.59 0.0001 0.0001 1.085(1.065, 1.105)
Skew normal regression: log scale 0.0001 0.32 3.56 0.0001 0.0001 1.134 (1.113, 1.155
FMM: raw scale 0.0001 4.68 33.70 0.0001 0.0001 0.795(0.737, 0.852)
LP, linear predictor. @, standardised residuals [13]. #, Deviance residuals [68].
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http://www.biomedcentral.com/1471-2288/12/68transformation showed poor approximation to standard
theoretical distributions (normal, lognormal and gamma;
Figure 2).
Comparative performance of the estimators for ICU
length of stay is seen in Tables 2 and 3; the regression mod-
els had 52 fixed parameters, including the constant term.
Over the range of measures assessing predictive perform-
ance and model specification (including goodness-of-fit),
the LMM demonstrated a consistently better performance
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Figure 3 Histograms of predicted mean ICU days for component 1 (lerevealed some problematic aspects of residual analyses. BIC
for all the log-scale estimators (LMM, treatment effects-
and log-skew-regressions) were considerably less than for
estimation on the raw scale (Table 2). The final model vari-
able set displayed a condition number of 19.4 and a mean
VIF of 3.76; the best R2 and concordance correlation coeffi-
cient was 0.22 and 0.334 respectively.
The outcome discrimination (Died-in-ICU) of the probit
sub-equation of the treatment effects regression was excel-
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TRTRG log scale: validation
Figure 4 Upper panel: Violin plots of ICU length of stay (raw-scale, length of stay < 16 days) and predicted length of stay (raw-scale,
< 16 days; determination and validation data sets) for estimators: OLS (raw-scale), log-scale OLS, LMM, and treatment effects
regression. Lower panel: Hosmer-Lemeshow (F) test of residuals across deciles of linear-predictor, for estimators: OLS (raw-scale), log-scale OLS,
LMM, and treatment effects regression. X-axis, linear predictor; Y-axis, parameter estimates.
Moran and Solomon BMC Medical Research Methodology 2012, 12:68 Page 9 of 17
http://www.biomedcentral.com/1471-2288/12/68
Figure 5 (See legend on next page.)
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Figure 5 Upper panel: Violin plots of ICU length of stay (raw-scale, length of stay < 16 days) and predicted length of stay (raw-scale,
< 16 days; determination and validation data sets) for estimators: GLM Poisson-log, GLM negative binomial-log, GLM gamma-log, GLM
inverse Gaussian-log. Lower panel: Hosmer-Lemeshow (F) test of residuals across deciles of linear-predictor, for estimators: GLM Poisson-log,
GLM negative binomial-log, GLM gamma-log, GLM inverse Gaussian-log. X-axis, linear predictor; Y-axis, parameter estimates. determin.,
determination. Validat., validation.
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http://www.biomedcentral.com/1471-2288/12/68area 0.92). The null hypothesis, that the correlation
(ρ=0.065) between the error terms of the separate estima-
tions is zero, was rejected at P=0.0001. The Poisson GLM
exhibited overdispersion (P value for “z”=0.0001), the
negative binomial GLM demonstrating an expected de-
crease in BIC; other performance measures were compar-
able between these two models. However, over-fitting, as
assessed by the Copas test, was demonstrated in all other
models except for the negative binomial GLM (Table 3).
The “GLM family test” of the variance function of GLMs
(Var[y|x] =α.[E(y|x)]γ [60]) rejected tests of γ for 0, 1, 2 and
3 (P≤0.0001). The modified Park test generated estimates
for γ of: 0.348(0.333, 0.364) for log-scale OLS; 1.659(1.609,
1.708) for GLM Poisson-log; 2.106(2.005, 2.207) for GLM
gamma-log; and 2.352(2.088, 2.616) for GLM inverse
Gaussian-log. The EEE link parameter (λ) estimate was
0.152(0.019, 0.285) and the variance function (θ2) was 2.115
(2.013, 2.218). The log-skew-normal and log-skew-t regres-
sions reported α values of 1.073(0.933, 1.213) and 1.490
(1.323, 1.659) respectively, suggesting positive-skew; the
degrees-of-freedom for the log-skew-t regression was 10.53
(7.97, 13.91) implying heavier-than-normal tails for the con-
ditional distribution of (log) ICU length-of-stay. The 2
component FMM gamma model generated predicted mean
ICU days of 0.56(0.32), range 0.06, 3.64 (component 1) and
3.69(2.45), range 0.49, 19.1 (component 2) as illustrated in
Figure 3. The FMM negative binomial models demon-
strated non-convergence.
Figures 4, 5, 6 show (i) upper panels: violin-plot distribu-
tional form of predictions and (ii) lower panels: Hosmer-
Lemeshow-test parameter estimates, for determination and
validation sets for each of the estimators, grouped by in-
creasing scalar values of the Hosmer-Lemeshow parameter
estimates. The graphical displays show a progressive lack-
of-fit (Hosmer-Lemeshow test estimates) across Figures 4,
5, 6 in concert with corresponding over- and under-
prediction as revealed by the violin plots. The LMM, log-
scale OLS and treatment effects regression were the best
calibrated; the EEE showed good calibration across the lin-
ear predictor deciles except for the upper deciles where
substantial discordance was evident.
The β regression estimates for the binary variable
“Died-in-ICU” are seen in Table 4, final column, and
range from a low of 29% (treatment effects regression) to
295% (raw-scale OLS).The average marginal effects are
also tabulated, and were generally decreased in magni-
tude compared with the β estimates. Figure 7 illustratesthe contrasts of predictive margins for “Died-in-ICU”
across increments of APACHE III score for raw-scale
OLS and log-link Gaussian family GLM (see also Table 4).
Similar decreases (not shown) of the contrasts of predict-
ive margins across the APACHE III score range were evi-
dent for the (log) linear predictor for estimators using
log-ICU length of stay.
Discussion
Methodological recommendations for non-normal data
analysis have usually been subsumed under the rubric of
cost analysis [12,15,69]. The distribution of positive
health expenditures (and length of stay) exhibit skew,
kurtosis and heteroscedasticity, with a non-constant and
increasing variance, albeit particular cost problems, such
as the accommodation of a probability mass at “zero”,
may not have immediate relevance to length of stay ana-
lysis [51,69]. This review has suggested that a LMM had
better overall performance compared with 11 other esti-
mators. However, a number of issues pertain to com-
parator studies of possible estimators; in particular data
structure and the full assessment, or otherwise, of model
specification.
The hierarchical nature of some clinical and/or admin-
istrative data sets and the requirement for appropriate
analysis has been commented upon above. As opposed
to the volume-outcome literature [70], mixed models
would appear to have been have been applied in a rela-
tively small number of studies for length of stay analysis
[16,71-75]. The use of administrative data [5,16] may
also be associated with integer based calendar–day
recording which lacks the accuracy of fractional day
based “exact” times [10,71].
Because of the non-normality of length of stay, formal
trimming [76,77] or truncation [71,77,78] of the data, or
deleting [5,73,79] “outliers” has been undertaken prior to
possible data transformation. For instance, studies imple-
menting the APACHE III [78] or IV [71] algorithms for
predicting ICU length of stay have truncated the latter at
30 days, at a 1% data level; the same fraction as seen with
data deletions [73]. The current study used a deletion
fraction of 0.001%. The motivation for such strategies are
various [80], but the theoretical basis of these data revi-
sions has been questioned [29] and bias in the estimation
of the mean has also been suggested [29,69]. More im-
portantly, large values of length of stay are “true” values
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FMM: validation
Figure 6 Upper panel: Violin plots of ICU length of stay (raw-scale, length of stay < 16 days) and predicted length of stay (raw- scale,
< 16 days; determination and validation data sets) for estimators: EEE, log-skew-t regression, log-skew-normal regression and FMM.
Lower panel: Hosmer-Lemeshow (F) test of residuals across deciles of linear-predictor, for estimators: EEE, log-skew-t regression, log-skew-normal
regression and FMM. X-axis, linear predictor; Y-axis, parameter estimates.
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Table 4 β regression estimate and average marginal effect for “Died in ICU”
β estimate Average marginal effect
OLS raw scale 2.947 (2.368, 3.526) 2.486 (2.060, 2.912)
OLS log scale 0.404 (0.302, 0.507) 0.353 (0.268, 0.437)
LMM log scale 0.367 (0.318, 0.416) 0.320 (0.285, 0.355)
Treatment effects regression: log scale 0.297 (0.194, 0.401) 0.215 (0.125, 0.302)
GLM: family(Poisson), link(log) 0.600 (0.444, 0.676) 1.456 (1.064, 1.848)
GLM: family(negative binomial), link(log) 0.596 (0.476, 0.715) 1.679 (1.239, 2.119)
GLM: family(gamma), link(log) 0.619 (0.497, 0.740) 1.802 (1.336, 2.269)
GLM: family(inverse Gaussian), link(log) 0.757 (0.608, 0.906) 2.648 (1.914, 3.382)
EEE: raw scale 0.678 (0.539, 0.817) 1.507 (1.042, 1.972
Skew-t regression: log scale 0.376 (0.268, 0.483) 0.335 (0.250, 0.420)
Skew normal regression: log scale 0.314 (0.214, 0.413) 0.271 (0.195, 0.348)
FMM: raw scale, component 1 0.234 (0.121, 0.347) 0.130 (0.066, 0.195)
FMM: raw scale, component 2 0.648 (0.513, 0.784) 2.395 (1.871, 2.920)
GLM: family(Gaussian), link(log) 0.541 (0.421, 0.662) 1.285 (0.902, 1.667)
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http://www.biomedcentral.com/1471-2288/12/68“. . .represent[ing] unusual cases. . .”, or because of
“. . .analytical problems. . .” [73]. That trimming will cause
decreases in residual variance in LMM was pointed out
by Lee et al. [72] and was easily demonstrated in the
current data set; where the residual variance was 0.646
for the full data, 0.600 at the 99th percentile trim (<
26 days) and 0.508 for the 95th percentile trim (< 12 days)
of ICU length of stay. Model assessment must take note
of data revisions.
Similarly, the repeated assertions [71,72,76,77,80,81]
that the objective of such data manipulations are model
(in particular, OLS) requirements for normality of the
dependent variable are problematic. As observed by Bun-
tin and Zaslavsky “Plotting of the data with various trans-
formations is thus a useful preliminary step, but
ultimately the distribution of the residuals from the trans-
formed model is critical because the model assumptions
concern the distribution of the residuals, not of the data”
[59]. That the residuals “. . .usually have a similar distribu-
tion to the original data. . .” [12] does not absolve the ana-
lyst from model based residual interrogation; the simple
reporting of overall measures such as R2 [77] or agreement
indices of observed versus predicted [71] are not satisfac-
tory proxies. Moreover, inference on β-coefficients is biased
under heteroscedasticity.
Effect of ICU death on length of stay.
The β coefficient for “Died-in-ICU”, as a main effect,
ranged from +29.7% (treatment effects regression, log
scale) to +300% (OLS, raw scale), consistent with the β
estimates for the factor “Death” of +0.536 (age <65 years)
and +0.439 (age≥ 65 years) reported by Angus et al. [5],
using a GLM (geometric family, identity link). However,
the results of the marginal analysis (Table 4) implied over-
prediction of the β-coefficient of “Died in ICU” across theestimators, albeit the average marginal effect was consid-
ered, as opposed to the marginal effect at the mean or at a
particular value [65,66]. Furthermore, there was a progres-
sive decrease in the contrast, died in ICU versus alive in
ICU, of predicted mean ICU days with an increase in the
APACHE III score (Figure 7); this effect being consistent
with findings from our previous study [82] and those of
Rapaport et al. [8] and Woods et al. [9]. Of more interest
was the demonstration, using the treatment effects regres-
sion model, that the covariate “Died-in-ICU” (which also
has the status of an “outcome”) was associated with a
significant correlation (ρ) between the error terms of the
separate estimations (probit and linear regression) and was
appropriately considered as endogenous [26]. That ρ was
positive at 0.065 also indicated that OLS overestimated the
“treatment” effect (Died-in-ICU); that is, a face-value inter-
pretation of the β mortality coefficient was problematic.
Endogeneity may also be suspected in mortality models
where length of stay [7] or mortality probability [83] are
entered as predictive covariates. Such regression of a vari-
able upon its components has been termed a “dubious
practice” [15]. This being said, the extension of 2-stage
methods to non-linear models may not be without its own
issues [15,84,85].
Estimators of length of stay.
The statistical basis of the various estimators used in
the current paper has been canvassed in “Statistical
methods”, above. These estimators, assessing the mean
function u xð Þ , have seen extensive application and as-
sessment in the cost data literature, but not necessarily
for length of stay. The recent introduction of log-skew-
normal and log-skew-t estimators has not afforded
opportunity for extensive assessment. Within the ICU








































































































Contrasts of Predictive Margins: GLM log-Gaussian
Figure 7 Contrasts of predictive margins (ICU days) across the binary variable “died in ICU” for OLS raw scale (upper panel) and GLM,
Gaussian family and log link (lower panel).
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http://www.biomedcentral.com/1471-2288/12/68ordinary least squares regression, with [8] and without
[7,71,78] log transformation; generalized linear model
(geometric family with identity link) [5] and random
intercept linear model [83]. Lee and co-workers have
explored alternative approaches suited to the analysis of
hospital length of stay [74,86].It is perhaps not surprising that in a large hierarchic-
ally structured data set that the LMM appeared to dom-
inate. The suggestion of lack of discriminatory power
across alternative estimators in cost analysis, albeit with
small sample size [15], also appears to be vindicated in
the current analysis. However, the further suggestion
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http://www.biomedcentral.com/1471-2288/12/68that large sample size together with “. . .simple meth-
ods. . .” [69] and an identity link [12,15] may be analytic-
ally sufficient seems not to be the case with our data,
although the LMM and log-OLS models were relatively
easy to fit and interpret. The estimated link function
(λ=0.152(0.019, 0.285) supports neither an identity (λ=1)
nor log link (λ=0), rather a fractional- but not a square-
root (λ=0.5) function. Although the Park test and the
EEE estimation of the variance function approximated 2,
the GLM variants demonstrated poor goodness-of-fit
(Figure 5) with the exception of the EEE (not with-
standing the upper most decile of the linear predictor,
Figure 6) where the link and variance functions were
estimated, not fixed. The narrow confidence limits in
the Copas test (Table 3) for the EEE estimator presum-
ably reflects this re-estimation of link and variance
functions in the cross-validation process. The residual
behaviour of (i) the log scale estimators (Table 3) was
generally satisfactory and empirical estimation suggested
a quadratic mean-variance relationship which was con-
sistent with the log-OLS estimator and (ii) the GLM
models, was variable and with heavy tails. The use of
gamma distribution in the presence of heavy tails has
recently been cautioned [69]. Estimators on the raw
scale (OLS and FMM) demonstrated consistent but sub-
optimal residual behaviour; and despite modest BIC
values, the log-skew estimators had an overall poor
residual performance.
In the current study, the range of R2 was modest
(0.18-0.22; Table 2); consistent with that previously
reported, 0.13 [78] to 0.21 [71,83], and the observations
of Diehr et al. that R2 for cost utilisation data are usu-
ally ≤ 0.20 [12]. Increases in R2 have been reported, not
surprisingly, across groupings; for instance, ICU units
(R2 = 0.78; [7]). In the current study, R2 across ICU units
(n = 118) was 0.92 (LMM, determination set).
Critique of methodology
The hierarchical structure of data under analysis is not
uncommon in clinical or administrative data sets, but
may not be seen in cost utilisation studies where survey
and administrative data predominate. Thus cross para-
digm performance assessments may lack validity, al-
though the skew and kurtosis indices (4.4 and 29.4
respectively, in the current data) at least were compar-
able (4.1 and 25.6 [42], 4.4 and 50 [50]). The significance
of the residual tests (Table 3) and the tendency to over-
fitting must be interpreted in the context of the large
data sets [87] and the reported adverse effect of outliers
and skewed data on these tests [15,42]. We chose not to
benchmark goodness of fit against the behaviour of raw
residuals from the log-scale estimators. This preference
was dictated by the application of homoscedastic
retransformation from log-scale estimation which maynot have been optimal, leading to the generation of raw-
scale residuals ( yi  y^i ) of uncertain status. Such
uncertainty may be contrasted with the fixed relation-
ship (via the inverse logit function) between the scale of
estimation (log-odds) and the scale of interest (probabil-
ity) in logistic regression where the Hosmer-Lemeshow
test was first described. No generally applicable method
of heteroscedastic retransformation recommends itself
with large data sets and multiple predictor variables
[39,42,51,59] and was not undertaken. Our analysis
suggests that percentage changes in days are important,
not absolute changes; this follows from the fact that the
data satisfy important optimal statistical properties on
the log scale, and that we can therefore estimate and in-
terpret effects on this scale with some confidence.
Comparisons between estimators with respect to the
significance (or otherwise), the effect magnitude and form
(for continuous variables) of other covariates entered into
the regressions (the covariates were fixed [11,59]) were not
a focus of interest and were not reported. The relatively
poor performance of the GLM model variants may be sub-
ject to enhancement by the use of generalised linear mixed
models [88] which could incorporate the random effects
structure of the LMM. Similarly, our use of the Poisson
and negative binomial GLM fails to account for the struc-
tural exclusion of zero counts (both distributions include
zeros) and use of zero-truncated count models may have
been appropriate [47].Conclusion
Model choice under the conditions of the current data
set would appear to favour the LMM and log-OLS. The
treatment effects model afforded extra explanation with
respect to the covariate “Died-in-ICU” and had a good
fit to the data. Mechanistic approaches to estimation are
represented by the FMM which captures the bi-modal
nature of the data (Figures 1 and 3), although the fit was
not optimal; and the negative binomial GLM which
represented the length of stay as “waiting times”. Neither
the log-skew-normal nor log-skew-t estimator would ap-
pear to recommend themselves as the preferred analytic
approach for the current data set.
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